MAPT and cerebrovascular disorder: The unavailability of tau-PET data for our subjects is another limitation since tau contributes to atrophy and may be partly dependent on supra-threshold levels of amyloid load.50 Furthermore, some of our participants may have concomitant pathologies, such as cerebrovascular disease.